Proteon Therapeutics Inc (NASDAQ:PRTO) investors are wildly disappointed today amid the firm’s Phase 3 sunken ship for its sole drug contender vonapanitase, sending …
Achaogen Inc (NASDAQ:AKAO) investors are partying around after the company announced surprisingly positive results from both Phase 3 trials of plazomicin in CRE …
Cowen analyst Boris Peaker weighed in on Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) with a few insights after the company announced that following a recent meeting with …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) hosted an analyst meeting last night at the American Epilepsy Society (AES) meeting that was met with marked …
Cowen analyst Ritu Baral is out with a research report on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after conducting separate surveys of 25 …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is anticipated to announce data from the Phase 2 trial of pimavanserin in Alzheimer’s Disease Psychosis (ADP) come December.
Nivalis Therapeutics Inc (NASDAQ:NVLS) shares are collapsing nearly 60% after the biotech firm’s cavosonstat’s Phase II proof-of-concept trial in F508del homozygous cystic fibrosis …
After Amicus Therapeutics, Inc. (NASDAQ:FOLD) met with the FDA and received written minutes, the biotech firm revealed yesterday that with the present data …
This morning, Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced a licensing and collaboration agreement with Vivelix for rights to develop and market IMO-9200, a TLR …
Shares of Juno Therapeutics Inc (NASDAQ:JUNO) fall as Wall Street continues to debate the unexpected patient deaths and clinical hold for the company’s Phase …
